INTRODUCTION
Biotechnology refers to a collection of techniques that uses living organisms or their products to make or modify a product, to improve plants or animals, or to develop microorganisms for specific uses (Abelson, 1992; Glick and Pasternak, 2003; Phillips, 2002) .
As new techniques emerge, the use of biotechnology to address emerging needs expands across various disciplines; including forensic science, pharmacology, medical technology, and agriculture.
Commercial adoption of plant biotechnology techniques has resulted in numerous agronomic traits including: increased nutrient-use efficiency, increased pest and pathogen resistance, and enhanced herbicide tolerance (James, 2014) . In 1999, glyphosate-resistant varieties of soybean, cotton, and maize were released. Since that time, multiple techniques have been applied to addressing various agronomic issues. Today, global production of biotech crops totals more than 448 million acres of commercial farmland (James, 2014) .
The potential for biotech to positively impact human and animal health, agricultural sustainability, and land use efficiency are well documented (Ciftci, 2000; Datta, 2013; Gersbach et al., 2007; Radakovits et al., 2010) . However, there are several obstacles to the development and deployment of crops with biotech-derived, value-added traits: (1) most crop genomes are large and repetitive, which makes it computationally difficult to select targets for gene editing;
(2) insufficient facilities (including greenhouse space) limit the scale of experiments that can be pursued; and (3) prohibitive costs associated with regulatory and licensing limit the number of biotech traits brought to market. In addition, the public perception of biotech as it pertains to food can be described as mixed at best. Many people are concerned that biotech crops -and 2 food products derived from them -are unsafe, a perspective that is not supported by scientific evidence (Blancke et al., 2015; Boudry et al., 2014; Giddings, 2015) .
My research focuses on the first major obstacle: creating efficient genome analysis tools to enable development of improved lines and cultivars. In Chapter 2, I describe the current set of design tools for CRISPR-based gene editing, with emphasis on the CRISPR Genome Analysis Tool (CGAT) I co-developed with programmer Scott Zarecor. In Chapter 3, I describe my efforts to design functional knockouts of the major peanut allergen Ara h 1 using the CRISPR/Cas system for gene editing. This exercise is one example of how biotechnology can be used to develop traits to positively impact human health and food safety. In Chapter 4, I describe these projects' potential for positive impact and discuss whether and how they relate to public perception of biotech in agriculture.
Early in the 20th century Muller showed that X-rays cause genetic mutations in Drosophila . Likewise, Stadler showed the mutational effects of X-rays on barley and maize which paved the way for researchers to broadly use mutagens such as X-rays and chemical agents to induce random genetic changes.
However, those methods yielded many mutations that had to be sorted out over generations to isolate the one responsible for causing changes to specific phenotypes/traits of interest. More recently, basic research to understand the processes underlying natural chromosomal recombination, microbial immune and virulence responses, and DNA binding domains led to discoveries that have made possible the development of targeted genome editing techniques that pair sequence-specific DNA binding proteins with enzymes that cleave DNA (reviewed in (Wright et al., 2014) . Development of these methods led to the realization that a RNA directed bacterial immune system could also be developed into an effective genome editing tool. Now three major systems for genome editing exist: Zinc Finger Nucleases (ZFNs), TAL Effector Nucleases (TALENs), and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs)-CRISPR associated proteins 9 (CRISPR-Cas9; reviewed in .
Zinc finger proteins are classified into distinct families based on specific structural motifs. Shared among all are DNA binding domains along with one or more zinc ion(s) that serve to stabilize the fold . Early NMR spectroscopy experiments revealed that the Cys2His2 zinc finger binding domain in the Xenopus transcription factor IIA is comprised of a 30 amino acid repeat sequence with conserved ββα secondary structure (Ruiz i . This architecture allows amino acids on the surface of the α-helix to interact with specific major groove nucleotides, thus conferring specificity for particular double-stranded DNA sequences (Beerli and Barbas, 2002) ; ; . It was later found that by changing amino acids in the α-helix, DNA binding specificity and affinity could be altered. Engineered zinc fingers were combined with the DNA cleavage domain of FokI, a type IIs restriction endonuclease, to form zinc finger nucleases (ZFNs), which were show to make specific targeted double-strand breaks in DNA.
Induction of DNA damage triggers the cellular repair pathway via error-prone nonhomologous end joining or template mediated homology directed repair thus giving limited control over the repair process in a targeted manner . Non-homologous end joining can create loss-of-function mutations due to insertions, deletions, or rearrangements whereas homology directed repair can create a precise mutation in the presence of a specific DNA template . ZFNs are known to cleave at off-target sites. This hampers their use and has been shown to cause cellular toxicity ; ). ZFNs are also difficult (and costly) to design and construct with variable rates of success (reviewed in ).
Transcription activator-like effector (TALE; also called TAL effector) proteins are major components of the type III secretion system conferring pathogenicity in the Gram negative bacteria Xanthomonas Mak et al., 2013) . Of the more than 30 families of bacterial effector proteins, TALEs are unique in their ability to distinguish specific DNA sequences via a central repetitive 34 amino acid DNA binding motif Streubel et al., 2012) . The repeat variable di-amino acids (RVDs) at positions 12 and 13 determine overall specificity and affinity for specific nucleotides in a target sequence. When coupled with the nuclease domain of Fok-I, TALE nucleases (TALENs) emerged as a novel genome-editing tool ; ; (Boch et al., 2009 ).
Compared to ZFNs, TALEN-assisted genome editing has significantly reduced toxicity due to off-target effects; however, construct design complexity due to specific requirements in base composition coupled with a lack of support for the TALEN lentiviral delivery systems (reviewed in ; have held back broad adoption and use of TALENs .
The difficulties of both ZFN and TALEN techniques lie in designing and validating proteins that recognize specific DNA sequences. In contrast, the CRISPR system is RNA-mediated. CRISPR was originally identified as a defense mechanism that provides bacterial adaptive immunity to a wide range of potential pathogens ().
There are three major classes (types I, II, III) and ten subclasses of CRISPRs based on which specific CRISPR-associated (Cas) proteins and non-coding RNA species are involved Makarova et al., 2011) . The type II CRISPR-Cas9 system has been co-opted for gene editing.
The native CRISPR-Cas9 system (Figure 1 ; next page) is comprised of three distinct architectural components: a small non-coding transactivating CRISPR RNA (tracrRNA), an operon that encodes the Cas proteins, and a repeat array encompassing crRNA units comprised of a 5' 20-nucleotide targeting sequence and a 19-22 nucleotide repeat sequence (referred to as spacers; . Multiple studies suggest that Cas9 endonuclease activity requires a highly conserved 3' three nucleotide protospacer adjacent motif (PAM) directly preceding the target sequence .
PAM sequence composition is highly diverse depending on the CRISPR type/subtype with NGG representing the most effective trinucleotide for the CRISPR-Cas9 system of Streptococcus pyogenes .
The native CRISPR-Cas9 genome editing mechanism is broken into a 3 processes:
acquisition, expression, and interference Makarova et al., 2011) . Upon host infection, exogenous genetic elements are incorporated into the CRISPR locus (acquisition phase). These repeat sequences are then transcribed into noncoding precursor CRISPR RNAs (pre-crRNAs; expression phase). The Cas9 nuclease uses these guide RNA sequences to cleave invading plasmids or phage molecules including any double stranded DNA matching the CRISPR RNAs (interference). Double strand DNA breaks are repaired via non-homologous end joining or homology directed repair in vivo, frequently leading to errors or elimination of invading DNA.
FIGURE 1: The CRISPR-Cas adaptive immune system. Three processes underlie the system, acquisition, expression, and interference. Foreign DNA is shown entering the cell. During acquisition, target DNA (beige; next to the PAM sequence shown in green) is incorporated into the CRISPR locus. Expression involves transcribed target DNA into noncoding precrRNAs to which tracrRNAs attach. During interference the Cas9 endonuclease uses these sequences to target foreign DNA for cleavage.
To simplify the system for targeted mutation, researchers combined the endogenous tracrRNA and crRNA to produce effective single guide RNA (sgRNA) constructs with unique restriction sites for targeting oligo insertion. The broad applicability of CRISPR to gene editing in diverse species coupled with simple design rules has resulted in the development of myriad bioinformatics tools that aim to identify potential sgRNA target sites in genomes of interest. Although multiple CRISPR sequence design tools already exist, they
are not all the same. Some are user friendly, others are more difficult to use. Some are available via web servers, others are not available online. Many perform only a few steps in a full computational analysis and design pipeline, and deliver results that are voluminous with no mechanism to sort. In addition, few computational tools are solely dedicated to plant-based genomic analysis and fewer tools have been subjected to peer-review. To help researchers choose a tool that best suits their specific research needs, we compared the functionality of various CRISPR design software including our own, CGAT the CRISPR Genome Analysis
Tool.
CRISPR COMPUTATIONAL RESOURCES COMPARISON
Of the available CRISPR tools we evaluated (see Table 1 ), there are two major classes: those that enable researchers to query experimentally validated sgRNAs for which genetic stocks are available, and those that predict potential CRISPR targets in a given sequence. At the time of this writing, the only tool we find that is in the former category is CrisprGE, though we anticipate that other tools will develop such resources in the very near future. For the remainder of this discussion, we focus on tools that can be used to predict potential CRISPR targets given an input sequence. Multiple computational tools are available to aid in the prediction and design of CRISPR constructs to target specific genomic loci. Tools are classified based on whether they are available online via web server, ability to search by gene name, options to use alternate PAM sequences, options to predict off-targets (by genomic sequence similarity), whether identified target lists can be sorted and/or ranked, and whether all of these functions are aggregated within a single, all-in-one pipeline. Here we specifically highlight the functionality of 17 non-commercial CRISPR design tools and report on their comparative functionality (Table 2) . 
CRISPRseek, sgRNAcas9 and SSFinder are only available as stand-alone systems and require installation and configuration. CRISPR target sequences are identified and evaluated based on user input. These tools are best suited for users with some technical experience.
Traditional experimental labs looking to quickly parse an input for possible CRISPR targets/off-targets in their species of interest might be better served to try the tools accessible online via web server.
Beyond databases of validated CRISPR constructs and tools that must be downloaded and installed, myriad online tools exist that allow users to quickly parse an input to predict putative CRISPR targets. Tools in this category tend to allow the greatest amount of user flexibility in terms of sgRNA design criteria. As the CRISPR system continues to improve, specifications such as the ability to search non-canonical PAM sequences, an option to designate promoter-specific bases preceding the seed sequence, and improved prioritization for potential targets will provide the greatest expansion in utility across a multitude of genomes and cell types.
A major concern with targeted nuclease technology is the potential for off-target cleavage and associated toxicity. With this in mind, many tools check the rest of a genome for additional matches to predicted target sequences. Even more sophisticated tools produce a ranked output of CRISPR targets by interpreting off-target scores as a function of the overall sgRNA score.
Only CGAT, Crispr-P, Chop-Chop and CRISPRdirect offer access online, enable search by gene name, allow the use of non-canonical PAM sequences, predict off-targets, enable ranking of identified targets, and contains all of these functionalities within a single pipeline. Here we describe the functionality of CGAT and demonstrate its functionality as a specific example that shows how such tools work.
MATERIALS AND METHODS
CGAT is built upon a variety of technologies. PostgreSQL 9.3 (http://www.postgresql.org/)
is the relational database system (RDBMS). For data retrieval, CGAT makes use of PostgreSQL's procedural language extensibility with portions of the database query logic written in PL/Python (http://www.postgresql.org/docs/9.3/static/plpython.html). The current version of the parser that processes genomic fasta-formatted files into relational database tables is written in the Go programming language (version 1.4.2) (https://golang.org/).
The website itself is written in Python 2.7.x using the 1.8.2 version of the Django framework (https://www.djangoproject.com/). Finally, the client-side functionality of the tool is written in Javascript using the 1.3.9 version of the AngularJS framework (https://angularjs.org/).
Code is available online at https://github.com/ISU-Crop-Bioengineering-Consortium/crispr.
While the above technology stack is relatively stable, version numbers of discrete pieces of the stack are likely to change as CGAT and the individual technologies on which it is built mature over time.
RESULTS
In overview, the CGAT tool works in two steps. In step one, CRISPR targets are identified in a user-specified sequence of interest with the sequence being pasted into a text field or selected from a list of gene/gene model names from the species of interest. In the second step, potential off-targets are identified. These two functionalities encompass the following steps:
1. For each genome available to search above, the genome sequence has been parsed in advance for valid CRISPR target sequences. All found target sequences were exported to a SQL database along with some relevant metadata. Additionally, the transcript data for each gene has also been stored in the SQL DB for easy retrieval when a user opts to select the input sequence from a specific gene.
2. In the tool interface, Javascript is used to parse both the input sequence and its complement for valid CRISPR targets based on the user-provided search parameter (i.e., Target Length, GC Content and Allowed Nucleotide Repeats). The results are rendered in the browser and, for each found target sequence, a request is sent to the webserver to search the specified genome database for potential off-target matches.
3. For each request sent from the web browser to the webserver in the previous step, the server queries the database for the target genome with the user-provided search parameters.
4. Search results are filtered and sorted primarily by an identity score between an input subsequence (bases 6-18 for 21 base sequences or bases 6-20 for 23 base sequences) and the corresponding subsequences stored in the database.
Additional sorting is performed based on an identity score between the subsequence at bases 2-5 of the input sequence and the corresponding subsequences in the database.
5. Finally, the webserver returns the search results to the browser, which updates the existing 
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INTRODUCTION
Many members of the Leguminisae family (also called legumes or beans) of flowering plants are capable of forming symbiotic relationships with the nitrogen-fixing bacteria rhizobium (Phillips, 1980) . Grain legumes are some of the richest sources of plant-based protein in the world (USDA Nutrient Database). They also serve as an abundant source of oil and micronutrients. Crops within this family include common bean, soybean, chickpea, lentil, and peanut.
The National Peanut Board estimates that global peanut production totals about 29 million metric tons per year. The United States is a leading peanut producer -third in the world following China and India (http://www.nationalpeanutboard.org). Studies indicate that peanut is a rich source of monounsaturated fats and other nutrients, such as niacin and manganese, which have been linked to a reduced risk of heart related complications (Kris-Etherton et al., 2008) .
Aside from increased heart health, studies indicate that peanuts can be beneficial in preventing colon cancer as well as gallstones. Data published in the journal of Neurology, Neurosurgery, and Psychiatry suggest that peanut consumption may also play an important role in protecting individuals from the neurodegenerative properties of Alzheimer's and other diseases.
Given the relatively low cost of peanut and its high availability for consumption, it is unfortunate that up to fifteen million Americans have food allergies. Of those affected, peanut allergies account for the highest number of deaths per year of any other food borne allergen (Finkelman, 2010) . Indeed, peanut is becoming increasingly prevalent in industrial food processing (Chang et al., 2013; Zhao et al., 2012) , making it increasingly difficult for families to provide healthy and safe foods for affected children and adults alike.
In allergic individuals, the immune system responds to harmless foreign molecules causing a range of allergy symptoms from dermatitis to anaphylaxis and even death (Finkelman, 2010) . Upon ingestion, peanut allergens are introduced to the immune system via the mucosal lining of the abdomen. Epithelial cells, along the interior wall of the abdomen, transfer allergens to dendritic cells for further processing. Dendritic cells initiate degradation of peanut allergens into smaller peptide fragments that are exposed on the cell surface via the major histocompatibility complex (MHC) (He et al., 2015) . Naïve T-cell receptors recognize the MHC-peptide complex, and mediate the activation of specialized T-cells to trigger immune response (known as T-cell priming). T-cell priming prompts the release of interleukins IL-4, IL-5, and IL-13. Cytokine signaling encourages differentiation of B cells that mediate the production of allergen specific Immunoglobulin E (IgE) antibodies. Peanut specific IgE antibodies are tightly bound to the surface of mast cells, and act as extracellular allergen receptors (He et al., 2015) . Subsequent exposure to peanut protein triggers the release of antiinflamatory molecules associated with the tell-tale symptoms (i.e., swelling of the extremities, asthma, diarrhea, vomiting, and anaphylaxis; He et al. 2015; Finkelman 2010) .
Allergenicity is described as a measure of the ability to elicit an immune response. A total of eleven proteins are potentially involved in peanut allergenicity, four of which have been identified as the most important based on clinical tests -immunoblots, skin prick tests, ex viva basophil histamine release assays. They are Ara h 1, Ara h 2, Ara h 3 and Ara h 6 (Koppelman et. al. 2010) . Ara h 1 is one of the most extensively studied proteins of the Ara allergen quartet. It affects 35-95% of allergic individuals. Ara h 1 is a 65-kDa vicilin, which has a homotrimeric structure (Shin et al., 1998) . Like other seed storage proteins Ara h 1 comprises up to 12 -15% of the total peanut protein content. The concentration of Ara h 1 in peanuts increases with kernel size and protein expression is linked with peanut maturity. There are 21 linear epitopes on mature protein monomers with 14 in the core region of the trimer. The core region is buried during trimer formation, which could potentially explain its reduced activity relative to other major allergens (Cabanos et al., 2011; Chruszcz et al., 2011; Zhou et al., 2013) .
Ara h 3 is a 60 kDA trypsin inhibitor in the glycinin family. Ara h 3 is responsible for seed longevity and deterring the catabolic activity of proteases present in the abdomen of most predators (Koppelman et al., 2003; Zhou et al., 2013) .
Ara h 2 and Ara h 6 are seed storage proteins in the conglutin family. Clinical studies suggest that the 2S albumin Ara h 2 is the most severely allergenic of the two because of its ability to trigger inflammatory response from human basophils in greater than 90% of peanut allergic individuals (Maleki et. al. 2013 ). Ara h 2 has two isoforms (Ara h 2.01 and Ara h 2.02) and a 59% amino acid homology with Ara h 6. Both Ara h 2 and Ara h 6 have multiple disulphide-bridged cysteine residues that result in a tightly coiled, protease resistant, and heat stable core that plays a role in allergenicity. These antigens are particularly dangerous due to their ability to form intermolecular cross-links when roasted, making the allergic reaction more severe when people with peanut allergies ingest roasted peanuts. (Chu et. al. 2008 ) (Chen et. al. 2013 ) ( Li et. al. 2013 ) (Klemans et. al. 2013) Cultivated peanut (Arachis hypogea) is an allotetraploid (2x = 2n =40) in the genus
Arachis, consisting of approximately 69 species spanning 9 morphological classes, which originated in South America. Karyotyping and chromosomal morphology data presented by Krapovickas et al. (1994) In these studies we associate the known peanut allergens with their genomic location in the Arachis hypogea subgenomes in an effort to determine whether the allergens could be targeted for gene editing. For Ara h 1, we design a CRISPR-Cas9 construct for future experimentation and to serve as a test case toward developing reduced allergenicity peanut cultivars.
METHODS

Genomic location of known peanut allergens
Allergen sequence information for all known Arachis proteins were accessed via the Allergen.org database. Genomic locations of Ara proteins relative to each Arachis pseudomolecule were mapped using protein input sequences and BLASTp functionality (Altschul, 2005) available via PeanutBase.org (Dash et al 2016) . A protein-protein alignment was generated for each query against known proteins in each progenitor genome using default parameters.
Identification of CRISPR targets using CGAT
Subcloning and sequence analysis of the Ara h 1 gene was previously described by Viquez et al. (2004) . CRISPR targets were identified using the CRISPR Genome Analysis Tool (CGAT; described in Chapter 2). CGAT parameters were adjusted to assess 21 nucleotide targets with a maximum nucleotide repetition of 3, and overall GC content between 45 and 65%. Guide RNAs exhibiting single base pair mismatches within the eleven nucleotides adjacent to the 3' PAM sequence have been shown to abolish Cas9 recognition (Cong et al. 2013) . For this reason, potential for constructs to create off-target effects were evaluated based on percentage non-target 3' identity to the genuine target sequence. Table 1 lists the genomic location of each of the known peanut allergens. Here we focus on the major allergens Ara h 1, Ara h2, Ara h3, and Ara h6. Ara h 1 (Genbank accession ,263,038 -1,265,555, A06:1,278,069 -1,286,732, A06:1,778,238 -1,780,113, B06:21,966,364 -21,968,437, B06:22,154,349 -22,156,660, B06:22,165,994 -2,172,682 . Ara h 6 (Genbank accession AAD56337) has homeologs on chromosome eight of the A and B genomes associated with positions A08: 34,023,496 -34,113,800 and B08:14,077,897 -14,223,923, respectively. Of the major allergens, Ara h 1 was selected for further analysis due to its performance in clinical trials to elicit immune response, as well as its localization to a single chromosomal location on both progenitor genomes at locations A09:111191611 -111193663 and B09:145805360 -145807488 as mentioned above. Viquez et al. (2003) reported the sequence analysis and genomic structure of an Ara h 1 clone.
RESULTS
Results indicated an open reading frame containing four exons and three introns. The 5' UTR directly flanking the first exon is a 1,926 bp promoter, harboring 17 cis regulatory elements. Of the elements described, the strength of the Ara h 1 promoter is suggested by the existence of 
CONCLUSIONS AND FUTURE WORK
Peanut is an agriculturally important species. Unfortunately, the prevalence of peanut allergy continues to increase across multiple countries -particularly amongst school-aged children().
Despite national guidelines for managing school related incidence of allergen exposure, the increased use of peanut and peanut extracts in food processing continues to present a growing public health concern -especially for parents of affected children. School districts across the U.S. have taken proactive measures to enforce strict bans of nuts and nut products on school premises. While this presents a win for concerned parents, many experts agree that this sort of solution will not completely protect children with extreme allergies.
By designing constructs that aim to knock out the specific allergens in peanut, we hypothesize a possible alternative to complete avoidance of situations where peanuts are present is given. While it is not reasonable to recommend that children allergic to peanut eat peanuts that have the major allergens knocked out, the potential for a classmate inadvertently exposing an allergic child to an allergen by way of e.g., eating a peanut butter sandwich nearby is reduced, making the lunch room a safer place.
Gene editing of cultivated peanut has several obstacles including overall genomic complexity and involvement of many epitopes in the allergenicity complex. Multiple techniques have been applied to reducing peanut allergenicity including enzymatic exposure and RNA interference. Here we aimed to completely knock out the major allergen Ara h 1 by focusing on constructs that target the 5' end of copies of the gene in both the A and B genomes. Using CGAT and other bioinformatics analyses, a single sgRNA was selected for further analysis using experimental molecular techniques. Collaborators Peggy Ozias-Akins and Don Weeks at the University of Georgia and University of Nebraska, respectively, will receive these predictions.
This would enable them to design guide RNA constructs targeting the Ara h 1 gene for further analysis (Fig 4) .
Example Cas9 construct harboring sgRNA of interest FIGURE 4. Possible Cas9 sgRNA construct. U6 promoter (red) drives expression of the sgRNA (yellow). CMV promoter (purple) is used to drive expression of Cas9 endonuclease (blue). GFP (light green) used as a reporter gene to easly identify positive transformants.
Next steps for this work involve the creation of sgRNA constructs, introduction of constructs into peanut cultivars, and testing to insure that the genes of interest have been knocked out. Upon introduction of this Cas9 construct, double strand breaks are predicted to occur at nucleotide positions 29 -52 of the first exon of the two Ara h 1 homeologs (in both the A and B genomes).
Recovery of repaired double strand breaks would require error prone non-homologous end joining. Nucleotide changes that result in a large deletion or a premature stop codon would be ideal for downstream analyses. Downstream analyses would aim to elucidate whether functional protein knockouts produce viable seeds, as well as to determine whether flavor, mouth feel, nutrition, and seed filling are adversely affected by editing the Ara h 1 gene (Essam et al. 1982) . (Dienner et al. 1982) .
CHAPTER IV
CONCLUSIONS
In this thesis I described our efforts to create a generalized tool for gene editing then applied it (and other bioinformatics tools) to the problem of knocking out the major peanut allergen Ara h 1. "Hypoallergenicity" refers to a reduction in potential for an allergic reaction compared to other products (http://fda.gov). Multiple processes have been described to reduce human immuno-sensitivity to peanut proteins. One strategy is to select peanut cultivars with decreased allergen presence and introduce them into conventional breeding programs to decrease the total amount of antigen present in commercial peanut. Other strategies involve exposing peanut to enzymes or polymers that greatly reduce the presence of consequential proteins (Finkelman, 2010; Yu et al., 2011) . In a practical sense, the long-term goal of Chapter 3 is not to create a hypoallergenic peanut, per se. Because there are many proteins involved and individuals' sensitivity to different epitopes varies, even a peanut that has the major allergens knocked out cannot be guaranteed 'hypoallergenic' for any and all individuals. Instead, the two main goals of the work described in Chapter 3 are (1) to design a peanut that has reduced allergenicity in order to create cultivars that could be used to increase food safety and (2) to demonstrate a clearly beneficial use of biotech that is a consumer-centric win.
Both Chapters 2 and 3 relevant to a major discussion ongoing in public forums regarding the safety of biotech food. A recent study suggests that the overt public opposition to biotech food may be due to three major factors: (1) psychological essentialism, (2) misplaced emotion, and (3) teleological thinking (Blancke et al., 2015) . Because none of these issues of perception can readily be fully addressed using only facts, figures, and experimental data, it is clear that changing public perception toward greater support of biotech in the marketplace will require the concerted efforts of educators, extension specialists, outreach coordinators, and many others.
